Table 3.
Comorbidities | NAFLD | NASH |
---|---|---|
Obesity | 51% | 82% |
Hypertension | 39% | 67% |
Type 2 diabetes mellitus | 23% | 47% |
Hyperlipidaemia/dyslipidaemia | 69% | 72% |
Metabolic syndrome | 41% | 71% |
Abbreviations: NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis.